• Home
  • About
  • Clinical
  • Authors
  • Most read this year
  • GP Opinion
  • Videos & Podcasts
  • Professional
  • Comments policy
  • RACGP
  • poll
Menu

Filter
Feminist language being hijacked to market medical tests

Feminist language being hijacked to market medical tests

Narratives around empowerment and women’s rights are being co-opted to market interventions not backed by evidence, according to new research.


Consider MHT for bones: New menopause guideline

Consider MHT for bones: New menopause guideline

Almost a decade in the making, a toolkit refresh is the first to include advice on prescribing hormone therapy specifically for bone health.


Study linking HRT with dementia risk ‘unhelpful’

Study linking HRT with dementia risk ‘unhelpful’

Experts point out that no causal relationship between menopausal hormone therapy and dementia has been established.


RACGP opposes GLP-1 RA prescribing restrictions

RACGP opposes GLP-1 RA prescribing restrictions

Changing the authority type for initiating the diabetes medication will make it difficult for ‘already burdened’ GPs to negotiate, the PBS has been told.


Why TSH test results can lead to over-testing, over-treatment

Why TSH test results can lead to over-testing, over-treatment

Lifestyle review is recommended as the first intervention to reduce risk of unnecessary patient harms and resource wastage.


Debate over ‘doctor-approved’ weight loss drugs obtained online

Debate over ‘doctor-approved’ weight loss drugs obtained online

Is a GP-reviewed online questionnaire clinically sufficient to safely prescribe injectable medications without a face-to-face consultation? It depends who you ask.


Menopause hormonal treatments to retain PBS listing

Menopause hormonal treatments to retain PBS listing

While GPs have welcomed the news, there are concerns a subsequent price increase will represent further gaps in access to care.


‘Serious implications’ if menopause treatments removed from PBS

‘Serious implications’ if menopause treatments removed from PBS

Experts warn the proposed delisting of medications will not only impose cost-related issues, but potentially affect quality of life.


Outdated information still guides menopause management: Expert

Outdated information still guides menopause management: Expert

Understanding the risks and benefits of various menopausal therapies leads to better outcomes.


New breast cancer research has ‘immediate implications’

New breast cancer research has ‘immediate implications’

The study has produced fresh evidence about the use of androgens as a potential treatment for oestrogen receptor-positive breast cancer.


  • Previous
  • 1
  • 2
  • 3
  • Next
Pages: 2 of 3
RACGP newsGP ArticlesnewsGP

Terms and conditions | Privacy statement | RACGP | recruitGP | AJGP

© 2018 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807